Establishment and evaluation of four different types of patient-derived xenograft models

[1]  Anang A. Shelat,et al.  Orthotopic Patient-Derived Xenografts of Pediatric Solid Tumors , 2017, Nature.

[2]  J. Zhang,et al.  Establishment of patient-derived tumor xenograft (PDTX) models using samples from CT-guided percutaneous biopsy , 2017, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[3]  C. von Kalle,et al.  Patient‐derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B‐lymphoproliferation , 2017, International journal of cancer.

[4]  S. Ganesan,et al.  Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine , 2017, Front. Oncol..

[5]  Heidi Ledford.  US cancer institute to overhaul tumour cell lines , 2016, Nature.

[6]  Kangdong Liu,et al.  A method for establishing a patient-derived xenograft model to explore new therapeutic strategies for esophageal squamous cell carcinoma. , 2016, Oncology reports.

[7]  Joshua M. Korn,et al.  High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response , 2015, Nature Medicine.

[8]  M. J. van de Vijver,et al.  Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract , 2015, Journal of Translational Medicine.

[9]  Yingyong Hou,et al.  Establishment and characterization of esophageal squamous cell carcinoma patient-derived xenograft mouse models for preclinical drug discovery , 2014, Laboratory Investigation.

[10]  Astrid Magenau,et al.  Three-dimensional cancer models mimic cell-matrix interactions in the tumour microenvironment. , 2014, Carcinogenesis.

[11]  C. Creighton,et al.  Gene expression profile of A549 cells from tissue of 4D model predicts poor prognosis in lung cancer patients , 2014, International journal of cancer.

[12]  Daniel J. Freeman,et al.  Gene expression profiles can predict panitumumab monotherapy responsiveness in human tumor xenograft models. , 2013, Neoplasia.

[13]  Aik Choon Tan,et al.  Patient-derived tumour xenografts as models for oncology drug development , 2012, Nature Reviews Clinical Oncology.

[14]  E W Steyerberg,et al.  Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.

[15]  Horatiu Voicu,et al.  Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma. , 2012, Neuro-oncology.

[16]  Jean-Pierre Gillet,et al.  Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance , 2011, Proceedings of the National Academy of Sciences.

[17]  M. Hidalgo,et al.  A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer , 2011, Molecular Cancer Therapeutics.

[18]  C. Cordon-Cardo,et al.  Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited. , 2010, Cancer research.

[19]  K. Jin,et al.  Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review , 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[20]  A. Schnider,et al.  Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  Giovanni Parmigiani,et al.  A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. , 2009, Cancer research.

[22]  M. Hidalgo,et al.  Direct In Vivo Xenograft Tumor Model for Predicting Chemotherapeutic Drug Response in Cancer Patients , 2009, Clinical pharmacology and therapeutics.

[23]  David J. Chen,et al.  Influence of tumor cell and stroma sensitivity on tumor response to radiation. , 2007, Cancer research.

[24]  David J. Chen,et al.  Tumor cell radiosensitivity is a major determinant of tumor response to radiation. , 2006, Cancer research.

[25]  R. Hruban,et al.  An In vivo Platform for Translational Drug Development in Pancreatic Cancer , 2006, Clinical Cancer Research.

[26]  E. Sausville,et al.  Contributions of human tumor xenografts to anticancer drug development. , 2006, Cancer research.

[27]  M. Knapton,et al.  Can routine laboratory data guide empirical prescribing? , 2004, Journal of clinical pathology.

[28]  Zvi Fuks,et al.  Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.

[29]  D. Hallahan,et al.  Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation. , 2002, Cancer research.

[30]  M. Christian,et al.  Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials , 2001, British Journal of Cancer.

[31]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[32]  Douglas B. Evans,et al.  Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice , 2009, Nature Protocols.

[33]  Ralph H. Hruban,et al.  Surgical pathology dissection : an illustrated guide , 1996 .